EichorEICHOR
Study identifier: NCT07295691 Synced from ClinicalTrials.gov · August 02, 2026
● Recruiting

Autologous Serum Eye Drops in Dry Eye Syndrome

Condition: Autologous Serum Eye Drops · Dry Eye Syndrome  ·  Sponsor: The General Authority for Teaching Hospitals and Institutes

PhaseNA
Planned participants70
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Hossam A Hassan, MD  ·  00201026808348  ·  Dr.hossameabdalfataah@gothi.gov.eg

Always discuss trial participation with your own doctor first.

Locations (1)

The General Authority for Teaching Hospitals and InstitutesCairo, EgyptRecruiting

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07295691